These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11650173)
1. A noninstitutional review board comes of age. Herman SS IRB; 1989; 11(2):1-6. PubMed ID: 11650173 [No Abstract] [Full Text] [Related]
2. The noninstitutional review board: a case history. Herman SS IRB; 1984; 6(1):1-3, 12. PubMed ID: 11649540 [No Abstract] [Full Text] [Related]
3. Monitoring of drug tests is faulted. Eichenwald K N Y Times Web; 1998 Jun; ():A14. PubMed ID: 11647564 [No Abstract] [Full Text] [Related]
4. Current problems and trends in testing of human drugs--especially in regard to institutional review committees. Burrell CD Food Drug Cosmet Law J; 1975 Apr; 30(4):213-8. PubMed ID: 11663255 [No Abstract] [Full Text] [Related]
5. Is local review being circumvented? Meyers K IRB; 1982; 4(7):6. PubMed ID: 11651704 [No Abstract] [Full Text] [Related]
6. Medical and psychological experimentation on California prisoners. Herch F; Flower R Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107 [No Abstract] [Full Text] [Related]
7. Regulatory aspects of the distinction between research and medical practice. McCarthy CR IRB; 1984; 6(3):7-8. PubMed ID: 11649567 [No Abstract] [Full Text] [Related]
8. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern. Gordon B; Prentice E IRB; 1997; 19(2):8-11. PubMed ID: 11655323 [No Abstract] [Full Text] [Related]
9. Protection of human subjects; new drugs for investigational use; conforming amendments; final rule. U.S. Food and Drug Administration Fed Regist; 1984 Oct; 49(212):43637-8. PubMed ID: 11645532 [No Abstract] [Full Text] [Related]
10. Gene therapy and AIDS: a constitutional politics report. Carmen IH Politics Life Sci; 1993 Aug; 12(2):279-80. PubMed ID: 11654725 [No Abstract] [Full Text] [Related]
11. The case of two devices: disclosure to subjects following Phase IV ("post-marketing") research. Anderson JR; Jameton A; Reitemeier PJ; Prentice E IRB; 1995; 17(3):6-9. PubMed ID: 11654269 [No Abstract] [Full Text] [Related]
12. The concept of the IRB and bureaucratic reality: an exchange of letters. van Eys J; Levine RJ IRB; 1984; 6(4):8-10. PubMed ID: 11649563 [No Abstract] [Full Text] [Related]
13. The Food and Drug Administration's role in the protection of human subjects. Nightingale SL IRB; 1983; 5(1):6-9. PubMed ID: 11649511 [No Abstract] [Full Text] [Related]
14. Human experimentation: the review process in practice. Cowan DH Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165 [No Abstract] [Full Text] [Related]
15. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns. Kobasic DM J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168 [No Abstract] [Full Text] [Related]
16. The impact of IRBs on political science research. Cleary RE IRB; 1987; 9(3):6-10. PubMed ID: 11652494 [No Abstract] [Full Text] [Related]
18. Informed consent process is deemed "legally and ethically invalid" by witness. Maloney DM Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008 [No Abstract] [Full Text] [Related]
19. Testing drugs in pediatric populations: the FDA mandate. Tauer CA Account Res; 1999; 7(1):37-58. PubMed ID: 11657562 [No Abstract] [Full Text] [Related]
20. Protection of human subjects. United States Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819 [No Abstract] [Full Text] [Related] [Next] [New Search]